Senior Management

Joseph St. Laurent
Co-Founder
President/Chief Scientific Officer

Mr. St. Laurent co-founded Chemic Laboratories, Inc. in 1998 and currently serves as President and Chief Scientific Officer. Mr. St. Laurent's primary responsibility includes the management of technical affairs and business development, ensuring that the company offers unparalleled contract analytical, formulation development, API synthesis and small scale manufacturing to the pharmaceutical, specialty chemical, biotech, and medical device industries. Furthermore, Mr. St. Laurent has also offered his drug development and consulting expertise to a virtual pharmaceutical company serving as CSO since 2008, aiding in product process development.

Joseph St. Laurent's received his Bachelor of Science degree in Biology/Biochemistry from Bridgewater State College. Mr. St. Laurent also completed advanced postgraduate analytical, organic and physical chemistry studies (Bridgewater State College); advanced studies in Mass Spectral Data Interpretation (Analytical Education Center) and Management Development Studies (Suffolk University, Boston, MA).

Prior to establishing Chemic Laboratories, Inc., Mr. St. Laurent served for ten years in various technical and management roles at several New England Contract Research Organizations.

Additionally before entering the contract facility environment, Mr. St. Laurent served as a research associate studying with Dr. Marvin Natowitz, at the famed Eunice Kennedy Shriver Center. Mr. St. Laurent's research surrounded the area of childhood genetic disorders (specifically those caused by abhorrent levels of lysosomal enzymes) and implications of outside influences on the causation of such disorders.

Scott Goodrich
Co-Founder
Treasurer/Chief Financial Officer

As Treasurer and Chief Financial Officer of Chemic Laboratories, Inc., Mr. Goodrich has over 15 years of management experience, including 5 years in the biochemistry field and 8 years as a Financial Analyst/Head of New Product Development. His primary responsibilities include managing financial responsibilities, accounting and budgeting as well as overseeing the Marketing, Human Resources, Quality Assurance, Regulatory Affairs and Facility Operations Departments. Mr. Goodrich received his Bachelor of Science Degree in Biology with a Minor in Chemistry from Bridgewater State College.

Neil Pothier, Ph.D.
Director, Analytical Services

Dr. Pothier joined Chemic Laboratories, Inc. in 2001 and currently serves as the Director, Analytical Services with a focus on Extractable/Leachable studies. Dr. Pothier's primary responsibilities include the overall operation and technical direction of the analytical group including analytical method development, validation and guidance of such. Additionally, Dr. Pothier serves on the BioProcess System Alliance (BPSA) Extractables and Leachables subcommittee.

Dr. Pothier received his Bachelor of Arts Degree in Chemistry from Rhode Island College and his Ph.D. in Analytical Chemistry from the University of Rhode Island.

Dr. Pothier was employed for 8 years performing trace organic and inorganic analysis in support of Department of Defense (DOD) remediation & EPA superfund sites under the Contract Laboratory Program (CLP). He served for three years as Technical Laboratory Director for this multi-national organization. He then joined Chemic Laboratories in 2001 as group leader/principle investigator/study director in the Bio-Analytical Department, responsible for method development and validation of GLP assays suitable for pharmo-kinetic (pK) and toxicological studies. In 2002, the additional responsibilities of managing the CMC department, conducting physical and chemical measurements, method development & validation, force degradation and structural elucidation in support of numerous ANDA, IND, and 510K applications were added. In 2003, he was charged with managing the Extractable & Leachable group focused on conducting controlled extraction studies and leachable method development and validation on OINDP, injectables, implantables, parenterals, and single use bio-process systems.

Gerald Jones, Ph.D.
Director, Manufacturing/Organic Synthesis

Dr. Jones joined Chemic Laboratories, Inc. in 2001 and currently serves as the Director, Manufacturing/Organic Synthesis. He has played an integral role in Chemic's development as a multi-service, value added company, and has made significant contributions to Chemic's cGMP synthetic programs (fluorescent diagnostic dye; anticholinergic API; proprietary lactate esters). He is also responsible for the successful reformulation of a commercial veterinary product, and the development of novel transdermal gels. Additionally, Dr. Jones has been a member of the American Chemical Society for over 30 years, and is a member of the Division of Medicinal Chemistry within the ACS. He is also a member of the Northeastern Section of the ACS, and the American Association of Pharmaceutical Scientists.

Dr. Jones received his Bachelor of Science Degree in Chemistry from Waynesburg College. Subsequently, Dr. Jones completed advanced postgraduate research earning his Ph.D. in Synthetic Organic Medicinal Chemistry from Purdue University, where his two part thesis described the synthesis of novel tricyclic heterocycles, and the synthesis of various derivatives of the aminoglycoside antibiotic, kanamycin B.

After three years of postdoctoral research and teaching at the University of Houston, Dr. Jones accepted a joint appointment at Harvard Medical School/Brigham & Women's Hospital. Two years later, he joined Northeastern University where he worked on a variety of small molecules including levamisole derivatives, and aryloxypropanolamines. In 1986, he accepted a joint appointment at Harvard Medical School/Massachusetts General Hospital (Department of Radiology; [11C]- and [99mTc]-labeled fatty acids as potential myocardial imaging agents for PET and SPECT). In 1988, he joined the faculty of Northeastern University, where his funded research focused on the design and synthesis of heterobifunctional ligands for labeling neuronal nicotinic receptors, and the synthesis of organophosphorus antibacterial agents. He left Northeastern in 1995, where he relocated at the Massachusetts College of Pharmacy. In 1996, he joined RSP Amino Acid Analogues, Inc., a start-up company dedicated to the synthesis of enantiopure, orthogonally protected, unique a-amino acid analogues. As the Vice President of Chemistry, he was responsible for directing the research efforts of 4-6 synthetic organic chemists (Ph.D./BS), while expending ~65% of his time on multi-step, asymmetric, and chemoenzymatic syntheses.

Lisa Walsh
Director, QA /Regulatory Affairs and Marketing

As Director, QA/Regulatory Affairs and Marketing of Chemic Laboratories, Inc., Ms. Walsh has over 15 years of quality assurance, marketing and sales related experience. Her primary responsibilities include overseeing the daily operations of the Quality Assurance Unit and Regulatory Affairs Department, as well as implementing multiple marketing campaigns, creating literature, business development and multiple promotional activities. Ms. Walsh received her Master's Degree in Regulatory Affairs from Northeastern University and her Bachelor of Science Degree in Biology with a Minor in Psychology from Bridgewater State College.